Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
45.58B | 50.33B | 15.28B | 59.84B | 77.12B | Gross Profit |
45.58B | 36.44B | 15.28B | 59.84B | 77.12B | EBIT |
0.00 | 9.45B | 10.10B | 5.44B | 3.65B | EBITDA |
7.26B | 8.59B | -1.57B | 9.66B | 8.61B | Net Income Common Stockholders |
5.63B | 5.46B | -2.10B | 6.66B | 5.33B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
25.79B | 20.34B | 19.15B | 22.59B | 26.17B | Total Assets |
978.82B | 875.57B | 848.94B | 917.64B | 880.35B | Total Debt |
14.16B | 12.74B | 12.36B | 11.86B | 13.99B | Net Debt |
-11.63B | -1.44B | -6.80B | -10.73B | -12.17B | Total Liabilities |
925.86B | 826.85B | 792.56B | 14.63B | 16.61B | Stockholders Equity |
51.54B | 47.30B | 54.72B | 57.17B | 51.55B |
Cash Flow | Free Cash Flow | |||
26.49B | 20.42B | 35.94B | 47.41B | 20.05B | Operating Cash Flow |
26.49B | 20.42B | 17.73B | 23.16B | 20.05B | Investing Cash Flow |
-18.46B | -13.72B | -18.61B | -24.44B | -14.15B | Financing Cash Flow |
-4.17B | -5.04B | -3.00B | -2.05B | 663.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | C$71.15B | 14.45 | 11.03% | 4.09% | 7.64% | 9.22% | |
73 Outperform | C$43.79B | 8.25 | 16.48% | 1.14% | 13.82% | -6.68% | |
72 Outperform | $44.64B | 14.90 | 12.87% | 4.39% | -12.72% | -0.16% | |
71 Outperform | C$30.88B | 14.65 | 10.36% | 4.59% | 30.81% | -2.47% | |
69 Neutral | C$47.63B | 12.46 | 15.52% | 4.26% | -2.40% | 42.24% | |
66 Neutral | C$11.39B | 13.01 | 13.26% | 2.78% | -17.69% | 29.19% | |
64 Neutral | $13.79B | 10.52 | 9.20% | 4.24% | 17.25% | -7.60% |